As of Sep 22
| +0.39 / +0.78%|
The 27 analysts offering 12-month price forecasts for Sanofi have a median target of 53.60, with a high estimate of 59.92 and a low estimate of 44.83. The median estimate represents a +6.48% increase from the last price of 50.34.
The current consensus among 29 polled investment analysts is to Hold stock in Sanofi. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.